GeneDx bets that rare disease data can aid drug discoverynews2024-12-04T15:00:09+00:00December 4th, 2024|Endpoints News|
Pharma telehealth programs are catching on and raising questionsnews2024-11-19T14:30:46+00:00November 19th, 2024|Endpoints News|
A rare neurological disease is Sage’s last, best hope after failures in depressionnews2024-11-18T16:22:00+00:00November 18th, 2024|Endpoints News|
Yorvipath’s approval showcases biopharma’s interest in rare endocrine disordernews2024-11-11T16:15:06+00:00November 11th, 2024|Endpoints News|
Biotech industry worries over potential for RFK Jr. ally as FDA picknews2024-11-06T15:00:20+00:00November 6th, 2024|Endpoints News|
MASH drug developers chart path forward as more patients use GLP-1snews2024-11-04T15:00:55+00:00November 4th, 2024|Endpoints News|
